PDF herunterladen
Semin Thromb Hemost 2022; 48(04): 422-433
DOI: 10.1055/s-0041-1740267
Review Article

Venous Thromboembolism in Premature Neonates

Prem Fort
1   Department of Pediatrics, Division of Neonatology, Johns Hopkins University School of Medicine, Baltimore, Maryland
2   Johns Hopkins All Children's Maternal Fetal and Neonatal Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
3   Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
,
Kisha Beg
4   Department of Pediatrics, Division of Hematology/Oncology/Bone Marrow Transplantation, University of Oklahoma College of Medicine, Oklahoma City, Oklahoma
,
Marisol Betensky
3   Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
5   Department of Pediatrics, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland
6   Johns Hopkins All Children's Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
7   Johns Hopkins All Children's Heart Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
,
Amy Kiskaddon
3   Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
7   Johns Hopkins All Children's Heart Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
8   Department of Pediatrics, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
,
Neil A. Goldenberg
3   Johns Hopkins All Children's Institute for Clinical and Translational Research, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
5   Department of Pediatrics, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland
6   Johns Hopkins All Children's Cancer and Blood Disorders Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
7   Johns Hopkins All Children's Heart Institute, Johns Hopkins All Children's Hospital, St. Petersburg, Florida
8   Department of Pediatrics, Division of Cardiology, Johns Hopkins University School of Medicine, Baltimore, Maryland
9   Department of Medicine, Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, Maryland
› Institutsangaben
› Weitere Informationen
    Lizenzen und Reprints

Abstract

While the incidence of venous thromboembolism (VTE) is lower among children than adults, the newborn period is one of two bimodal peaks (along with adolescence) in VTE incidence in the pediatric population. Most VTE cases in neonates occur among critically ill neonates being managed in the neonatal intensive care unit, and most of these children are born premature. For this reason, the presentation, diagnosis, management, and outcomes of VTE among children born premature deserve special emphasis by pediatric hematologists, neonatologists, pharmacists, and other pediatric health care providers, as well as by the scientific community, and are described in this review.

Keywords

venous thromboembolism - infant - newborn - critical illness - preterm - neonate


Publikationsverlauf

Artikel online veröffentlicht:
23. Dezember 2021

© 2021. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • References

  • 1 Monagle P, Newall F. Management of thrombosis in children and neonates: practical use of anticoagulants in children. Hematology (Am Soc Hematol Educ Program) 2018; 2018 (01) 399-404
    CrossrefPubMedGoogle Scholar
  • 2 Amankwah EK, Atchison CM, Arlikar S. et al. Risk factors for hospital-associated venous thromboembolism in the neonatal intensive care unit. Thromb Res 2014; 134 (02) 305-309
    CrossrefPubMedGoogle Scholar
  • 3 Heller C, Schobess R, Kurnik K. et al; For the Childhood Thrombophilia Study Group. Abdominal venous thrombosis in neonates and infants: role of prothrombotic risk factors - a multicentre case-control study. Br J Haematol 2000; 111 (02) 534-539
    PubMedGoogle Scholar
  • 4 Morag I, Epelman M, Daneman A. et al. Portal vein thrombosis in the neonate: risk factors, course, and outcome. J Pediatr 2006; 148 (06) 735-739
    CrossrefPubMedGoogle Scholar
  • 5 van Elteren HA, Veldt HS, Te Pas AB. et al. Management and outcome in 32 neonates with thrombotic events. Int J Pediatr 2011; 2011: 217564
    CrossrefPubMedGoogle Scholar
  • 6 Raffini L, Huang Y-S, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124 (04) 1001-1008
    CrossrefPubMedGoogle Scholar
  • 7 Kenet G, Cohen O, Bajorat T, Nowak-Göttl U. Insights into neonatal thrombosis. Thromb Res 2019; 181 (Suppl. 01) S33-S36
    CrossrefPubMedGoogle Scholar
  • 8 Kenet G, Barg AA, Nowak-Göttl U. Hemostasis in the very young. Semin Thromb Hemost 2018; 44 (07) 617-623
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 9 Demirel N, Aydin M, Zenciroglu A. et al. Neonatal thrombo-embolism: risk factors, clinical features and outcome. Ann Trop Paediatr 2009; 29 (04) 271-279
    CrossrefPubMedGoogle Scholar
  • 10 Robinson V, Achey MA, Nag UP. et al. Thrombosis in infants in the neonatal intensive care unit: analysis of a large national database. J Thromb Haemost 2021; 19 (02) 400-407
    CrossrefPubMedGoogle Scholar
  • 11 Andrew M. Developmental hemostasis: relevance to thromboembolic complications in pediatric patients. Thromb Haemost 1995; 74 (01) 415-425
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 12 Tuckuviene R, Christensen AL, Helgested J, Hundborg HH, Kristensen SR, Johnsen SP. Infant, obstetrical and maternal characteristics associated with thromboembolism in infancy: a nationwide population-based case-control study. Arch Dis Child Fetal Neonatal Ed 2012; 97 (06) F417-F422
    CrossrefPubMedGoogle Scholar
  • 13 Strauss T, Levy-Shraga Y, Ravid B. et al. Clot formation of neonates tested by thromboelastography correlates with gestational age. Thromb Haemost 2010; 103 (02) 344-350
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 14 Cowman J, Quinn N, Geoghegan S. et al. Dynamic platelet function on von Willebrand factor is different in preterm neonates and full-term neonates: changes in neonatal platelet function. J Thromb Haemost 2016; 14 (10) 2027-2035
    CrossrefPubMedGoogle Scholar
  • 15 Michelson AD. Platelet function in the newborn. Semin Thromb Hemost 1998; 24 (06) 507-512
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 16 Linder N, Shenkman B, Levin E. et al. Deposition of whole blood platelets on extracellular matrix under flow conditions in preterm infants. Arch Dis Child Fetal Neonatal Ed 2002; 86 (02) F127-F130
    CrossrefPubMedGoogle Scholar
  • 17 Levy-Shraga Y, Maayan-Metzger A, Lubetsky A. et al. Platelet function of newborns as tested by cone and plate(let) analyzer correlates with gestational Age. Acta Haematol 2006; 115 (3-4): 152-156
    CrossrefPubMedGoogle Scholar
  • 18 Strauss T, Sidlik-Muskatel R, Kenet G. Developmental hemostasis: primary hemostasis and evaluation of platelet function in neonates. Semin Fetal Neonatal Med 2011; 16 (06) 301-304
    CrossrefPubMedGoogle Scholar
  • 19 Revel-Vilk S. The conundrum of neonatal coagulopathy. Hematology (Am Soc Hematol Educ Program) 2012; 2012: 450-454
    CrossrefPubMedGoogle Scholar
  • 20 Reverdiau-Moalic P, Delahousse B, Body G, Bardos P, Leroy J, Gruel Y. Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood 1996; 88 (03) 900-906
    CrossrefPubMedGoogle Scholar
  • 21 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the healthy premature infant. Blood 1988; 72 (05) 1651-1657
    CrossrefPubMedGoogle Scholar
  • 22 Andrew M, Paes B, Milner R. et al. Development of the human coagulation system in the full-term infant. Blood 1987; 70 (01) 165-172
    CrossrefPubMedGoogle Scholar
  • 23 Smith AA, Jacobson LJ, Miller BI, Hathaway WE, Manco-Johnson MJ. A new euglobulin clot lysis assay for global fibrinolysis. Thromb Res 2003; 112 (5-6): 329-337
    CrossrefPubMedGoogle Scholar
  • 24 Goldenberg NA, Hathaway WE, Jacobson L, Manco-Johnson MJ. A new global assay of coagulation and fibrinolysis. Thromb Res 2005; 116 (04) 345-356
    CrossrefPubMedGoogle Scholar
  • 25 Weisel JW, Litvinov RI. Fibrin formation, structure and properties. Subcell Biochem 2017; 82: 405-456
    CrossrefPubMedGoogle Scholar
  • 26 Swieringa F, Spronk HMH, Heemskerk JWM, van der Meijden PEJ. Integrating platelet and coagulation activation in fibrin clot formation. Res Pract Thromb Haemost 2018; 2 (03) 450-460
    CrossrefPubMedGoogle Scholar
  • 27 Versteeg HH, Heemskerk JW, Levi M, Reitsma PH. New fundamentals in hemostasis. Physiol Rev 2013; 93 (01) 327-358
    CrossrefPubMedGoogle Scholar
  • 28 Saracco P, Vitale P, Scolfaro C, Pollio B, Pagliarino M, Timeus F. The coagulopathy in sepsis: significance and implications for treatment. Pediatr Rep 2011; 3 (04) e30
    CrossrefPubMedGoogle Scholar
  • 29 Levi M, van der Poll T. Coagulation and sepsis. Thromb Res 2017; 149: 38-44
    CrossrefPubMedGoogle Scholar
  • 30 Bökenkamp A, von Kries R, Nowak-Göttl U, Göbel U, Hoyer PF. Neonatal renal venous thrombosis in Germany between 1992 and 1994: epidemiology, treatment and outcome. Eur J Pediatr 2000; 159 (1-2): 44-48
    CrossrefPubMedGoogle Scholar
  • 31 Saxonhouse MA, Manco-Johnson MJ. The evaluation and management of neonatal coagulation disorders. Semin Perinatol 2009; 33 (01) 52-65
    CrossrefPubMedGoogle Scholar
  • 32 Monagle P, Chan AKC, Goldenberg NA. et al. Antithrombotic therapy in neonates and children: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141 (2, Suppl): e737S-e801S
    CrossrefPubMedGoogle Scholar
  • 33 Saxonhouse MA. Thrombosis in the neonatal intensive care unit. Clin Perinatol 2015; 42 (03) 651-673
    CrossrefPubMedGoogle Scholar
  • 34 Stoll BJ, Hansen NI, Bell EF. et al; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Neonatal outcomes of extremely preterm infants from the NICHD Neonatal Research Network. Pediatrics 2010; 126 (03) 443-456
    Google Scholar
  • 35 Sheth RD. Trends in incidence and severity of intraventricular hemorrhage. J Child Neurol 1998; 13 (06) 261-264
    CrossrefPubMedGoogle Scholar
  • 36 Monagle P, Cuello CA, Augustine C. et al. American Society of Hematology 2018 Guidelines for management of venous thromboembolism: treatment of pediatric venous thromboembolism. Blood Adv 2018; 2 (22) 3292-3316
    CrossrefPubMedGoogle Scholar
  • 37 El-Naggar W, Yoon EW, McMillan D. et al; Canadian Neonatal Network Investigators. Epidemiology of thrombosis in Canadian neonatal intensive care units. J Perinatol 2020; 40 (07) 1083-1090
    CrossrefPubMedGoogle Scholar
  • 38 Rivard GE, David M, Farrell C, Schwarz HP. Treatment of purpura fulminans in meningococcemia with protein C concentrate. J Pediatr 1995; 126 (04) 646-652
    CrossrefPubMedGoogle Scholar
  • 39 White B, Livingstone W, Murphy C, Hodgson A, Rafferty M, Smith OP. An open-label study of the role of adjuvant hemostatic support with protein C replacement therapy in purpura fulminans-associated meningococcemia. Blood 2000; 96 (12) 3719-3724
    CrossrefPubMedGoogle Scholar
  • 40 Lexicomp Online. Enoxaparin. https://online.lexi.com/lco/action/home . Accessed November 9, 2021
    PubMedGoogle Scholar
  • 41 Bhandari M, Hirsh J, Weitz JI, Young E, Venner TJ, Shaughnessy SG. The effects of standard and low molecular weight heparin on bone nodule formation in vitro. Thromb Haemost 1998; 80 (03) 413-417
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 42 Garcia DA, Baglin TP, Weitz JI, Samama MM. Parenteral anticoagulants: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 2012; 141 (2, Suppl): e24S-e43S
    Google Scholar
  • 43 Bohnhoff JC, DiSilvio SA, Aneja RK. et al. Treatment and follow-up of venous thrombosis in the neonatal intensive care unit: a retrospective study. J Perinatol 2017; 37 (03) 306-310
    CrossrefPubMedGoogle Scholar
  • 44 Hicks JK, Shelton CM, Sahni JK, Christensen ML. Retrospective evaluation of enoxaparin dosing in patients 48 weeks' postmenstrual age or younger in a neonatal intensive care unit. Ann Pharmacother 2012; 46 (7-8): 943-951
    CrossrefPubMedGoogle Scholar
  • 45 Michaels LA, Gurian M, Hegyi T, Drachtman RA. Low molecular weight heparin in the treatment of venous and arterial thromboses in the premature infant. Pediatrics 2004; 114 (03) 703-707 d
    CrossrefPubMedGoogle Scholar
  • 46 Malowany JI, Monagle P, Knoppert DC. et al; Canadian Paediatric Thrombosis and Hemostasis Network. Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates. Thromb Res 2008; 122 (06) 826-830
    CrossrefPubMedGoogle Scholar
  • 47 Bauman ME, Belletrutti MJ, Bajzar L. et al. Evaluation of enoxaparin dosing requirements in infants and children. Better dosing to achieve therapeutic levels. Thromb Haemost 2009; 101 (01) 86-92
    Artikel in Thieme ConnectPubMedGoogle Scholar
  • 48 Lexicomp Online. Protamine. https://online.lexi.com/lco/action/home . Accessed November 9, 2021
    PubMedGoogle Scholar
  • 49 Giglia TM, Massicotte MP, Tweddell JS. et al; American Heart Association Congenital Heart Defects Committee of the Council on Cardiovascular Disease in the Young, Council on Cardiovascular and Stroke Nursing, Council on Epidemiology and Prevention, and Stroke Council. Prevention and treatment of thrombosis in pediatric and congenital heart disease: a scientific statement from the American Heart Association. Circulation 2013; 128 (24) 2622-2703
    CrossrefPubMedGoogle Scholar
  • 50 Andrew M, Marzinotto V, Massicotte P. et al. Heparin therapy in pediatric patients: a prospective cohort study. Pediatr Res 1994; 35 (01) 78-83
    CrossrefPubMedGoogle Scholar
  • 51 Alsoufi B, Boshkov LK, Kirby A. et al. Heparin-induced thrombocytopenia (HIT) in pediatric cardiac surgery: an emerging cause of morbidity and mortality. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2004; 7: 155-171
    CrossrefPubMedGoogle Scholar
  • 52 Risch L, Huber AR, Schmugge M. Diagnosis and treatment of heparin-induced thrombocytopenia in neonates and children. Thromb Res 2006; 118 (01) 123-135
    CrossrefPubMedGoogle Scholar
  • 53 Schmugge M, Risch L, Huber AR, Benn A, Fischer JE. Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care patients. Pediatrics 2002; 109 (01) E10
    CrossrefPubMedGoogle Scholar
  • 54 Lexicomp Online. Warfarin Hudson, OH Lexicomp. Accessed November 9, 2021 at: https://online.lexi.com/lco/action/home
    PubMedGoogle Scholar
  • 55 Giglia TM, Witmer C, Procaccini DE, Byrnes JW. Pediatric cardiac intensive care society 2014 consensus statement: pharmacotherapies in cardiac critical care anticoagulation and thrombolysis. Pediatr Crit Care Med 2016; 17 (3, Suppl 1): S77-S88
    CrossrefPubMedGoogle Scholar
  • 56 Iyengar AJ, Winlaw DS, Galati JC. et al; Australia and New Zealand Fontan Registry. No difference between aspirin and warfarin after extracardiac Fontan in a propensity score analysis of 475 patients. Eur J Cardiothorac Surg 2016; 50 (05) 980-987
    CrossrefPubMedGoogle Scholar
  • 57 Monagle P, Cochrane A, Roberts R. et al; Fontan Anticoagulation Study Group. A multicenter, randomized trial comparing heparin/warfarin and acetylsalicylic acid as primary thromboprophylaxis for 2 years after the Fontan procedure in children. J Am Coll Cardiol 2011; 58 (06) 645-651
    CrossrefPubMedGoogle Scholar
  • 58 Lexicomp Online. Argatroban. https://online.lexi.com/lco/action/home . Accessed November 9, 2021
    PubMedGoogle Scholar
  • 59 Lexicomp Online. Bivalirudin. https://online.lexi.com/lco/action/home . Accessed November 9, 2021
    PubMedGoogle Scholar
  • 60 Young G, Boshkov LK, Sullivan JE. et al. Argatroban therapy in pediatric patients requiring nonheparin anticoagulation: an open-label, safety, efficacy, and pharmacokinetic study. Pediatr Blood Cancer 2011; 56 (07) 1103-1109
    CrossrefPubMedGoogle Scholar
  • 61 O'Brien SH, Yee DL, Lira J, Goldenberg NA, Young G. UNBLOCK: an open-label, dose-finding, pharmacokinetic and safety study of bivalirudin in children with deep vein thrombosis. J Thromb Haemost 2015; 13 (09) 1615-1622
    CrossrefPubMedGoogle Scholar
  • 62 Rayapudi S, Torres Jr A, Deshpande GG. et al. Bivalirudin for anticoagulation in children. Pediatr Blood Cancer 2008; 51 (06) 798-801
    CrossrefPubMedGoogle Scholar
  • 63 Young G, Tarantino MD, Wohrley J, Weber LC, Belvedere M, Nugent DJ. Pilot dose-finding and safety study of bivalirudin in infants <6 months of age with thrombosis. J Thromb Haemost 2007; 5 (08) 1654-1659
    CrossrefPubMedGoogle Scholar
  • 64 Tarango C, Manco-Johnson MJ. Pediatric thrombolysis: a practical approach. Front Pediatr 2017; 5: 260
    CrossrefPubMedGoogle Scholar
  • 65 Manco-Johnson MJ. How I treat venous thrombosis in children. Blood 2006; 107 (01) 21-29
    CrossrefPubMedGoogle Scholar
  • 66 El-Segaier M, Khan MA, Khan ZU, Momenah T, Galal MO. Recombinant tissue plasminogen activator in the treatment of neonates with intracardiac and great vessels thrombosis. Pediatr Cardiol 2015; 36 (08) 1582-1587
    CrossrefPubMedGoogle Scholar
  • 67 Hartmann J, Hussein A, Trowitzsch E, Becker J, Hennecke KH. Treatment of neonatal thrombus formation with recombinant tissue plasminogen activator: six years experience and review of the literature. Arch Dis Child Fetal Neonatal Ed 2001; 85 (01) F18-F22
    CrossrefPubMedGoogle Scholar
  • 68 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96 (5 Pt 1): 939-943
    CrossrefPubMedGoogle Scholar
  • 69 Andrew M, David M, Adams M. et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83 (05) 1251-1257
    CrossrefPubMedGoogle Scholar
  • 70 Kahn SR, Shrier I, Julian JA. et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med 2008; 149 (10) 698-707
    CrossrefPubMedGoogle Scholar
  • 71 Prandoni P, Lensing AW, Cogo A. et al. The long-term clinical course of acute deep venous thrombosis. Ann Intern Med 1996; 125 (01) 1-7
    CrossrefPubMedGoogle Scholar
  • 72 Goldenberg NA, Donadini MP, Kahn SR. et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010; 95 (11) 1952-1959
    CrossrefPubMedGoogle Scholar
  • 73 Engel ER, Nguyen ATH, Amankwah EK. et al. Predictors of postthrombotic syndrome in pediatric thrombosis: a systematic review and meta-analysis of the literature. J Thromb Haemost 2020; 18 (10) 2601-2612
    CrossrefPubMedGoogle Scholar
  • 74 Keidan I, Lotan D, Gazit G, Boichis H, Reichman B, Linder N. Early neonatal renal venous thrombosis: long-term outcome. Acta Paediatr 1994; 83 (11) 1225-1227
    CrossrefPubMedGoogle Scholar
  • 75 Zigman A, Yazbeck S, Emil S, Nguyen L. Renal vein thrombosis: a 10-year review. J Pediatr Surg 2000; 35 (11) 1540-1542
    CrossrefPubMedGoogle Scholar
  • 76 Kayemba-Kay's S. Spontaneous neonatal renal vein thrombosis, a known pathology without clear management guidelines: an overview. Int J Pediatr Adolesc Med 2020; 7 (01) 31-35
    CrossrefPubMedGoogle Scholar
  • 77 Messinger Y, Sheaffer JW, Mrozek J, Smith CM, Sinaiko AR. Renal outcome of neonatal renal venous thrombosis: review of 28 patients and effectiveness of fibrinolytics and heparin in 10 patients. Pediatrics 2006; 118 (05) e1478-e1484
    CrossrefPubMedGoogle Scholar
  • 78 Wasay M, Dai AI, Ansari M, Shaikh Z, Roach ES. Cerebral venous sinus thrombosis in children: a multicenter cohort from the United States. J Child Neurol 2008; 23 (01) 26-31
    CrossrefPubMedGoogle Scholar
  • 79 Moharir MD, Shroff M, Stephens D. et al. Anticoagulants in pediatric cerebral sinovenous thrombosis: a safety and outcome study. Ann Neurol 2010; 67 (05) 590-599
    CrossrefPubMedGoogle Scholar
  • 80 Moharir MD, Shroff M, Pontigon A-M. et al. A prospective outcome study of neonatal cerebral sinovenous thrombosis. J Child Neurol 2011; 26 (09) 1137-1144
    CrossrefPubMedGoogle Scholar
  • 81 Berfelo FJ, Kersbergen KJ, van Ommen CH. et al. Neonatal cerebral sinovenous thrombosis from symptom to outcome. Stroke 2010; 41 (07) 1382-1388
    CrossrefPubMedGoogle Scholar
  • 82 Jordan LC, Rafay MF, Smith SE. et al; International Pediatric Stroke Study Group. Antithrombotic treatment in neonatal cerebral sinovenous thrombosis: results of the International Pediatric Stroke Study. J Pediatr 2010; 156 (05) 704-710 , 710.e1–710.e2
    CrossrefPubMedGoogle Scholar
  • 83 Devlieger H, Snoeys R, Wyndaele L. et al. Liver necrosis in the new-born infant: analysis of some precipitating factors in neonatal care. Eur J Pediatr 1982; 138 (02) 113-119
    CrossrefPubMedGoogle Scholar
  • 84 Kim JH, Lee YS, Kim SH, Lee S-K, Lim MK, Kim HS. Does umbilical vein catheterization lead to portal venous thrombosis? Prospective US evaluation in 100 neonates. Radiology 2001; 219 (03) 645-650
    CrossrefPubMedGoogle Scholar
  • 85 Morag I, Shah PS, Epelman M, Daneman A, Strauss T, Moore AM. Childhood outcomes of neonates diagnosed with portal vein thrombosis. J Paediatr Child Health 2011; 47 (06) 356-360
    CrossrefPubMedGoogle Scholar